Author:
Matsumoto Kazuhiro,Hagiwara Masayuki,Tanaka Nobuyuki,Hayakawa Nozomi,Ishida Masaru,Ninomiya Akiharu,Nakajima Yosuke,Nakamura So
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference30 articles.
1. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol. 1997;79:235–46.
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guideline) prostate cancer, version 4. 2013. Fort Washington, PA.
3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD, et al. European Association of Urology (EAU) guidelines on prostate cancer, 2013 edition, Arnhem, the Netherlands.
4. Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst. 2003;95:981–9.
5. Cancer Registration Committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol. 2005;12:46–61.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献